Journal
/
/
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
DOI:

11:34 min

May 05, 2014

, , , , , ,

Chapters

  • 00:05Title
  • 01:34Preparation of 96-well Daughter Plates with Compounds
  • 03:03Preparation of Cell Cultures to Determine Compound Toxicity
  • 04:18Preparation of Cell Cultures Infected by rMV2/Luc
  • 05:37Luciferase Activity Measurement
  • 06:36Secondary Screening for Toxicity and Broad-spectrum Antiviral Activity
  • 08:52Results: Identification of Anti-viral Hit Compounds
  • 11:06Conclusion

Summary

Automatic Translation

In vitro assays to measure virus replication have been greatly improved by the development of recombinant RNA viruses expressing luciferase or other enzymes capable of bioluminescence. Here we detail a high-throughput screening pipeline that combines such recombinant strains of measles and chikungunya viruses to isolate broad-spectrum antivirals from chemical libraries.

Related Videos

Read Article